A European competence framework for industrial pharmacy practice in biotechnology

Jeffrey Atkinson, Pat Crowley, Kristien de Paepe, Brian Gennery, Andries Koster, Luigi Martini, Vivien Moffat, Jane Nicholson, Gunther Pauwels, Giuseppe Ronsisvalle, Vitor Sousa, Chris van Schravendijk, Keith Wilson

Research output: Contribution to journalArticlepeer-review

Abstract

Project Report: The PHAR-IN ("Competences for industrial pharmacy practice in biotechnology") looked at whether there is a difference in how industrial employees and academics rank competences for practice in the biotechnological industry. A small expert panel consisting of the authors of this paper produced a biotechnology competence framework by drawing up an initial list of competences then ranking them in importance using a three-stage Delphi process. The framework was next evaluated and validated by a large expert panel of academics (n = 37) and industrial employees (n = 154). Results show that priorities for industrial employees and academics were similar. The competences for biotechnology practice that received the highest scores were mainly in: . "Research and Development", . "Upstream" and "Downstream" Processing', " . "Product development and formulation", " . "Aseptic processing", ."Analytical methodology", . "Product stability", and . "Regulation". The main area of disagreement was in the category "Ethics and drug safety" where academics ranked competences higher than did industrial employees.
Original languageEnglish
Pages (from-to)101-128
Number of pages27
JournalPharmacy
Volume3
Issue number3
DOIs
Publication statusPublished - 29 Jul 2015

Bibliographical note

© 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/).

Keywords

  • education
  • pharmacy
  • industry
  • Europe
  • biotechnology

Fingerprint Dive into the research topics of 'A European competence framework for industrial pharmacy practice in biotechnology'. Together they form a unique fingerprint.

Cite this